Teachers Retirement System of The State of Kentucky decreased its holdings in shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) by 7.9% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 34,820 shares of the software maker’s stock after selling 3,000 shares during the period. Teachers Retirement System of The State of Kentucky’s holdings in Allscripts Healthcare Solutions were worth $444,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in MDRX. UBS Asset Management Americas Inc. raised its holdings in Allscripts Healthcare Solutions by 31.6% during the first quarter. UBS Asset Management Americas Inc. now owns 129,106 shares of the software maker’s stock worth $1,637,000 after purchasing an additional 30,966 shares in the last quarter. Karp Capital Management Corp purchased a new position in Allscripts Healthcare Solutions during the first quarter worth about $205,000. Ameriprise Financial Inc. raised its holdings in Allscripts Healthcare Solutions by 1.2% during the first quarter. Ameriprise Financial Inc. now owns 479,719 shares of the software maker’s stock worth $6,082,000 after purchasing an additional 5,586 shares in the last quarter. Parametric Portfolio Associates LLC raised its holdings in Allscripts Healthcare Solutions by 116.1% during the first quarter. Parametric Portfolio Associates LLC now owns 358,644 shares of the software maker’s stock worth $4,548,000 after purchasing an additional 192,664 shares in the last quarter. Finally, Prudential Financial Inc. raised its holdings in Allscripts Healthcare Solutions by 5.6% during the first quarter. Prudential Financial Inc. now owns 111,917 shares of the software maker’s stock worth $1,419,000 after purchasing an additional 5,960 shares in the last quarter.

In related news, CEO Paul Black sold 15,000 shares of the business’s stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $13.52, for a total value of $202,800.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Brian Farley sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $13.52, for a total transaction of $67,600.00. Following the completion of the sale, the executive vice president now owns 196,607 shares in the company, valued at $2,658,126.64. The disclosure for this sale can be found here. Insiders sold a total of 35,000 shares of company stock worth $473,800 over the last quarter. Insiders own 0.75% of the company’s stock.

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) opened at 14.08 on Friday. The stock’s 50 day moving average is $13.83 and its 200-day moving average is $12.71. The stock’s market capitalization is $2.54 billion. Allscripts Healthcare Solutions, Inc. has a 52 week low of $9.80 and a 52 week high of $14.45.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its earnings results on Thursday, August 3rd. The software maker reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.04). Allscripts Healthcare Solutions had a positive return on equity of 5.97% and a negative net margin of 11.54%. The business had revenue of $426.10 million during the quarter, compared to the consensus estimate of $424.94 million. During the same quarter in the previous year, the firm earned $0.14 earnings per share. The firm’s revenue for the quarter was up 10.2% compared to the same quarter last year. Equities research analysts forecast that Allscripts Healthcare Solutions, Inc. will post $0.61 EPS for the current year.

MDRX has been the subject of several analyst reports. BidaskClub raised shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a report on Saturday, June 24th. Piper Jaffray Companies reissued a “hold” rating and set a $14.00 price target on shares of Allscripts Healthcare Solutions in a report on Friday, July 21st. Maxim Group reissued a “buy” rating and set a $16.00 price target on shares of Allscripts Healthcare Solutions in a report on Friday, August 4th. Morgan Stanley increased their price target on shares of Allscripts Healthcare Solutions from $11.00 to $12.00 and gave the stock an “underweight” rating in a report on Monday, August 7th. Finally, Citigroup Inc. increased their price target on shares of Allscripts Healthcare Solutions from $13.00 to $14.00 and gave the stock a “neutral” rating in a report on Monday, August 7th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and twelve have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $15.24.

ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/10/22/teachers-retirement-system-of-the-state-of-kentucky-sells-3000-shares-of-allscripts-healthcare-solutions-inc-mdrx.html.

Allscripts Healthcare Solutions Profile

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Stock Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related stocks with our FREE daily email newsletter.